TCR-T NY-ESO-1 targeting T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TCR-T NY-ESO-1 targeting T cells, covering 2016-08-03 to 2016-08-03. Get the full timeline:
Most recent: Clinical Trial Update: T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies [Phase 1]